Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cannabis and Thought Disorder in Schizophrenia: Clinical and Neuroimaging Relationships

NCT03608137 is registered in ClinicalTrials.gov with Hôpital le Vinatier as lead sponsor.

NCT NCT03608137
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03608137 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cannabis and Thought Disorder in Schizophrenia: Clinical and Neuroimaging Relationships
Lead sponsor
Hôpital le Vinatier
Phase
Not applicable
Overall status
Terminated
Start date
December 7, 2018
Completion date
December 31, 2022
Enrollment
63 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia